SCLX Q3 2022 Earnings — Scilex Holding Company Revenue & Financial Results | Market Cap Arena

SCLXScilex Holding Company

$73M

Q3 2022 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$11M+36.7% YoY

Gross Profit

$8M68.3% margin

Operating Income

-$11M-93.3% margin

Net Income

$22M189.0% margin

EPS (Diluted)

$0.16

QoQ Revenue Growth

+43.5%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

$3M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$89M

Total Liabilities

$318M

Stockholders' Equity

-$229M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$8M	+36.7%
Gross Profit	$8M	$7M	+8.6%
Operating Income	-$11M	-$7M	-44.2%
Net Income	$22M	-$12M	+278.9%